Literature DB >> 10395476

Structure-based design, synthesis, and X-ray crystallography of a high-affinity antagonist of the Grb2-SH2 domain containing an asparagine mimetic.

P Furet1, C García-Echeverría, B Gay, J Schoepfer, M Zeller, J Rahuel.   

Abstract

Previous efforts in the search for molecules capable of blocking the associations between the activated tyrosine kinase growth factor receptors and the SH2 domain of Grb2 had resulted in the identification of 3-amino-Z-pTyr-Ac6c-Asn-NH2, a high-affinity and selective antagonist of this SH2 domain. In the present paper, we report the successful replacement of asparagine in this compound by a beta-amino acid mimetic, which brings us closer to our objective of identifying a Grb2-SH2 antagonist suitable for pharmacological investigations.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10395476     DOI: 10.1021/jm991013u

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  6 in total

1.  Rationale for Bcl-xL/Bad peptide complex formation from structure, mutagenesis, and biophysical studies.

Authors:  A M Petros; D G Nettesheim; Y Wang; E T Olejniczak; R P Meadows; J Mack; K Swift; E D Matayoshi; H Zhang; C B Thompson; S W Fesik
Journal:  Protein Sci       Date:  2000-12       Impact factor: 6.725

2.  Conformationally constrained peptidomimetic inhibitors of signal transducer and activator of transcription. 3: Evaluation and molecular modeling.

Authors:  Pijus K Mandal; Donald Limbrick; David R Coleman; Garrett A Dyer; Zhiyong Ren; J Sanderson Birtwistle; Chiyi Xiong; Xiaomin Chen; James M Briggs; John S McMurray
Journal:  J Med Chem       Date:  2009-04-23       Impact factor: 7.446

3.  Solution structure of the Grb2 SH2 domain complexed with a high-affinity inhibitor.

Authors:  Kenji Ogura; Takanori Shiga; Masashi Yokochi; Satoru Yuzawa; Terrence R Burke; Fuyuhiko Inagaki
Journal:  J Biomol NMR       Date:  2008-10-02       Impact factor: 2.835

4.  Computer applications for prediction of protein-protein interactions and rational drug design.

Authors:  Solène Grosdidier; Max Totrov; Juan Fernández-Recio
Journal:  Adv Appl Bioinform Chem       Date:  2009-11-10

5.  Synthesis and structural characterization of a monocarboxylic inhibitor for GRB2 SH2 domain.

Authors:  Tao Xiao; Luxin Sun; Min Zhang; Zilu Li; Eric B Haura; Ernst Schonbrunn; Haitao Ji
Journal:  Bioorg Med Chem Lett       Date:  2021-09-07       Impact factor: 2.823

6.  Development of Grb2 SH2 Domain Signaling Antagonists: A Potential New Class of Antiproliferative Agents.

Authors:  Terrence R Burke
Journal:  Int J Pept Res Ther       Date:  2006-03-14       Impact factor: 1.931

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.